Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas

Human Pathology

Volumn 27, Issue 4, 1996, Pages 350-354

  Langford, Lauren A ^a   Cooksley, Catherine S ^a   Demonte, Franco ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

bromodeoxyuridine; Ki 67; meningioma; MIB 1; proliferation index

Indexed keywords

BOVINE SERUM ALBUMIN; BROXURIDINE; CELL MARKER; CYCLINE; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HEMANGIOPERICYTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; MUTAGENESIS;

EID: 0029913754     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90107-0     Document Type: Article

References (24)

1. Jääskeläinen J: Seemingly complete removal of histologically benign intracranial meningioma: Late recurrence rate and factors predicting recurrence in 657 patients: A multivariate analysis. Surg Neurol 25:461-469, 1986
2. Jellinger K, Slowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 208:279-298, 1975
3. Ng HK: Atypical and malignant meningioma: Any easy diagnostic criteria? Adv Anat Pathol 1:44-48, 1994
4. Hall PA, Levison DA: Assessment of cell proliferation in histological material. J Clin Pathol 43:184-192, 1990
5. Bruner JM, Langford LA, Fuller GN: Neuropathology, cell biology, and newer diagnostic methods. Curr Opin Oncol 5:441-449, 1993
6. Hsu DW, Pardo FS, Efird JT, et al: Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 53:247-255, 1994
7. Lee KS, Hoshino T, Rodriguez LA, et al: Bromodeoxyuridine labeling study of intracranial meningiomas: Proliferative potential and recurrence. Acta Neuropathol 80:311-317, 1990
8. Cattoretti G, Becker MH, Key G, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363, 1992
9. Key G, Becker MHG, Baron B, et al: New Ki-67-equivalent murine monoclonal antibodies (MIB-1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68:629-636, 1993
10. Schlüter C, Duchrow M, Wohlenberg C, et al: The cell proliferation-associated antigen of antibody Ki-67: A very large ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123:513-522, 1993
11. Gottschalk J, Goebel S, Jautzke G, et al: Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas. Histol Histopathol 7:653-661, 1992
12. Kurki P, Lotz M, Ogata K, et al: Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 138:4114-4120, 1987
13. Burford-Mason AP, MacKay AJ, Cummins M, et al: Detection of proliferating cell nuclear antigen (PCNA) in paraffin-embedded specimens is dependent on pre-embedding tissue handling and fixation. Arch Pathol Lab Med 118:1007-1013, 1994
14. Diebold J, Lai MD, Lorhs U: Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA): Methodological aspects and application to routine diagnostic material. Virchows Arch [Cell Pathol] 62:283-289, 1992
15. Nishizaki T, Orita T, Furutani Y, et al: Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors: J Neurosurg 70:379-384, 1989
16. Fukui M, Iwaki T, Sawa H, et al: Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir (Wien) 81:135-141, 1986
17. Hoshino T, Ito S, Asai A, et al: Cell kinetic analysis of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine. Int J Cancer 50:1-5, 1992
18. Hoshino T, Nagashima T, Murovic JA, et al: Proliferative potential of human meningiomas of the brain: A cell kinetics study with bromodeoxyuridine. Cancer 58:1466-1472, 1986.
19. Shibuya M, Hoshino T, Ito S, et al: Meningiomas: Clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 30:494-498, 1992
20. Shibuya M, Ito S, Miwa T, et al: Proliferative potential of brain tumors: Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Cancer 71:199-206, 1993
21. Kharbanda K, Karak AK, Sarkar C, et al: Prediction of biologic aggressiveness in human meningiomas: A cell kinetic study using bromodeoxyuridine in cells of primary explant culture. J Natl Cancer Inst 84:194-195, 1992
22. Meyer JS, Marchosky A, Hickey WF: Cell kinetic classification by DNA precursor labeling in vitro. HUM PATHOL 24:1357-1364, 1993
23. Roggendorf W, Schuster T, Peiffer K: Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73:361-364, 1987
24. Karamitopoulou E, Perentes E, Diamantis I, et al: Ki-67 immunoreactivity in human central nervous system tumors: A study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87:47-54, 1994